A Trio of Catalysts Propels SpaceX Forward

SpaceX experienced a significant boost from three separate developments this week, combining to create powerful momentum for the private space company. The news spans major government contracts, operational milestones in human spaceflight, and regulatory approval for a key expansion of its satellite internet constellation, collectively fueling discussions about its long-anticipated public market debut.

Regulatory Green Light and Revenue Trajectory

In a move with substantial long-term implications, the Federal Communications Commission (FCC) granted SpaceX permission to significantly expand its Starlink satellite network. The authorization allows the deployment of up to 15,000 satellites, featuring newer “V2 Mini Optimized” models designed for higher bandwidth and direct-to-cell capabilities. This expansion is central to the company’s financial projections. Current forecasts suggest SpaceX could generate between $22 billion and $24 billion in revenue by 2026, a notable jump from the $15.5 billion estimated for 2025. Within these figures, the Starlink segment is projected to contribute approximately 70% of total sales, supported by a user base expected to exceed 8.5 million by the end of 2025.

Defense Department Commitment and ISS Demonstration

Simultaneously, SpaceX’s role as a critical government partner was reinforced. The U.S. Space Force’s Space Systems Command (SSC) awarded the company a $739 million contract covering nine National Security Space Launch (NSSL) missions under Phase 3, Lane 1. The launch schedule for these missions is outlined as follows: SDA-2 in the fourth quarter of fiscal year 2026, SDA-3 in the third quarter of 2027, and NTO-5 between the first quarter of 2027 and the second quarter of 2028. These missions are aimed at enhancing low-Earth orbit satellite constellations to improve missile warning and tracking capabilities.

In a separate but equally significant operational event, NASA and SpaceX coordinated an accelerated return of a Crew-11 astronaut from the International Space Station due to an undisclosed medical issue. The Crew Dragon spacecraft undocked on January 14, with splashdown occurring off the California coast on January 15. While NASA did not detail the medical condition, it confirmed the affected crew member was in stable condition. The incident served as a practical, real-world test of SpaceX’s emergency return protocols for its human spaceflight operations.

Should investors sell immediately? Or is it worth buying SpaceX?

Path to a Potential Public Listing

This confluence of events has intensified market speculation regarding a potential SpaceX initial public offering (IPO). Media reports from January 9 have cited a possible valuation target of around $1.5 trillion for a listing in the mid-to-late 2026 timeframe. Such a valuation, based on price-to-sales metrics, would place SpaceX significantly above traditional aerospace and defense contractors. However, analysts caution that these figures remain speculative and are contingent upon the company continuing to execute on its operational goals.

The company also maintains a dominant position in the commercial launch sector, currently holding an estimated 82% market share.

Near-Term Milestones to Watch

Attention now turns to imminent developments. The successful conclusion of the Crew-11 medical return mission is seen as a key confidence-builder for NASA’s commercial crew program. Furthermore, an operational update expected in the first quarter of 2026 is anticipated to provide crucial details on Starship reusability progress and long-term cost-per-kilogram targets, which are ambitiously set between $100 and $200. Achieving these technical and cost milestones is widely viewed as fundamental to securing sustainable profit margins and, ultimately, a robust valuation for any future IPO.